Related Experiment Video
Updated: Aug 9, 2026

10:53
Real-time Imaging of Axonal Transport of Quantum Dot-labeled BDNF in Primary Neurons
Published on: September 15, 2014
[Neurotrophin-like low molecular weight compounds]
1Department of Welfare Engineering, Faculty of Engineering, Iwate University, 4-3-5 Ueda, Morioka-shi, Iwate 020-8551, Japan. tsatoh@iwate-u.ac.jp
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|December 21, 2002
Summary
Researchers are exploring novel prostaglandins to promote brain function recovery and neuronal survival. These compounds offer a promising therapeutic avenue for neurodegenerative diseases, overcoming blood-brain barrier limitations.
Area of Science:
- Neuroscience
- Pharmacology
Context:
- Limited therapeutic options exist to enhance brain function recovery post-insult.
- Neurotrophins show promise but face delivery challenges due to the blood-brain barrier.
- Low-molecular-weight compounds offer an alternative therapeutic strategy.
Purpose:
- To review novel neurite outgrowth-promoting prostaglandins.
- To evaluate their potential as therapeutic agents for neurodegenerative diseases.
Summary:
- Newly synthesized prostaglandins, derived from anti-tumor cyclopentenone prostaglandin structures, exhibit neurotrophic effects.
- These compounds promote neurite outgrowth and neuronal survival in the central nervous system.
- They represent a potential alternative to neurotrophins for treating brain injury and neurodegeneration.
Impact:
- These prostaglandins may offer a viable therapeutic strategy for enhancing brain function recovery.
- They could provide new treatment options for patients suffering from neurodegenerative diseases.
- This research opens avenues for developing novel neuroprotective and neuroregenerative agents.
Related Concept Videos
Enzyme-linked Receptors
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
Immunoglobulin-like Cell Adhesion Molecules
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...

